Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strontium ranelate for osteoporosis in men
2006-004717-17Phase 3Terminated
- Sponsor
- Servier
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Strontium ranelate 2 g with Placebo (2 arms). Primary endpoint: Lumbar spine bone mineral density. Started Jan 2007; status: terminated.
02
Drugs
strontium ranelate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2006-004717-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004717-17.